M1肌性受体的混合体调节剂 提高乙胆的有效性,降低斑马鱼的运动活动和转向行为
Corey J Widman1, Sestina Ventresca1, Jillian Dietrich1
1University of Toledo.
Research square
|February 27, 2024
概括
新的阳性全调节剂 (PAM) 增强肌酸乙胆受体 (mAChR) 疗效,有望治疗像自闭症谱系障碍 (ASD) 这样的神经系统疾病,并降低毒性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 肌肉酸乙胆受体 (mAChRs) 的全调节是一种神经疾病的治疗策略.
- 大多数阳性全调节剂 (PAM) 增强激动剂亲和力,但很少有选择性地提高G蛋白合功效.
研究的目的:
- 为了研究阿米奥达龙增强mAChR疗效的结构特征.
- 与阿米奥达龙相比,开发具有更好的疗效,安全性和结合亲和力的新杂交配体.
- 评估这些化合物在斑马鱼体内的体内作用.
主要方法:
- 研究了表达M1受体的CHO细胞中阿米奥达龙的结构特征.
- 将这些特征纳入n-基异氨酸中,以创建混合联结体.
- 评估了斑马鱼的结合亲和力,G蛋白合功效,以及体内毒性和行为.
主要成果:
- 混合配方体表现出与阿米奥达龙相比具有可比或优异的mAChR疗效增强,较低的毒性和更高的结合亲和力.
- 化合物8a和8b分别显示出最强的结合亲和力和疗效增强.
- 斑马鱼的研究表明,8a和8c化合物降低了运动运动活动,增加了转行为.
结论:
- 对mAChR疗效的Allosteric调节为具有重复行为特征的神经精神疾病 (如自闭症谱系障碍) 提供了潜在的治疗途径.
- 混合配体代表了一类有前途的化合物,其有效性和安全性在向mAChRs方面得到了改善.
相关概念视频
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
968
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
968
Cholinergic Receptors: Muscarinic
2.2K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.2K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.3K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K


